Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Becker_JU:

[Report from the Heart, Vascular, Renal, and Transplantation Pathology Working Group]. Becker JU et al. Pathologe. (2017)

Current status of pediatric renal transplant pathology. Becker JU et al. Pediatr Nephrol. (2017)

[Report from the cardiac, vascular, renal, and transplantation pathology working group]. Becker JU et al. Pathologe. (2015)

Search results

Items: 1 to 20 of 129

1.

A 2018 Reference Guide to the Banff Classification of Renal Allograft Pathology.

Roufosse C, Simmonds N, Groningen MC, Haas M, Henriksen KJ, Horsfield C, Loupy A, Mengel M, Perkowska-Ptasińska A, Rabant M, Racusen LC, Solez K, Becker JU.

Transplantation. 2018 Jul 19. doi: 10.1097/TP.0000000000002366. [Epub ahead of print]

PMID:
30028786
2.

Pathological manifestations of Farber disease in a new mouse model.

Beckmann N, Kadow S, Schumacher F, Göthert JR, Kesper S, Draeger A, Schulz-Schaeffer WJ, Wang J, Becker JU, Kramer M, Kühn C, Kleuser B, Becker KA, Gulbins E, Carpinteiro A.

Biol Chem. 2018 Sep 25;399(10):1183-1202. doi: 10.1515/hsz-2018-0170.

PMID:
29908121
3.

Correction to: Phenytoin inhibits necroptosis.

von Mässenhausen A, Tonnus W, Himmerkus N, Parmentier S, Saleh D, Rodriguez D, Ousingsawat J, Ang RL, Weinberg JM, Sanz AB, Ortiz A, Zierleyn A, Becker JU, Baratte B, Desban N, Bach S, Schiessl IM, Nogusa S, Balachandran S, Anders HJ, Ting AT, Bleich M, Degterev A, Kunzelmann K, Bornstein SR, Green DR, Hugo C, Linkermann A.

Cell Death Dis. 2018 May 24;9(6):622. doi: 10.1038/s41419-018-0638-2.

4.

[Antifreeze poisoning : The case of a patient with repeated ethylene glycol poisoning].

Prinz J, Böll B, von Bergwelt M, Burst V, Becker JU, Carvalho-Fiel D, Shimabukuro-Vornhagen A, Kochanek M.

Med Klin Intensivmed Notfmed. 2018 Apr 12. doi: 10.1007/s00063-018-0439-5. [Epub ahead of print] German.

PMID:
29651677
5.

Author Correction: Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.

Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU.

Sci Rep. 2018 Apr 12;8(1):6003. doi: 10.1038/s41598-018-23760-1.

6.

Phenytoin inhibits necroptosis.

von Mässenhausen A, Tonnus W, Himmerkus N, Parmentier S, Saleh D, Rodriguez D, Ousingsawat J, Ang RL, Weinberg JM, Sanz AB, Ortiz A, Zierleyn A, Becker JU, Baratte B, Desban N, Bach S, Schiessl IM, Nogusa S, Balachandran S, Anders HJ, Ting AT, Bleich M, Degterev A, Kunzelmann K, Bornstein SR, Green DR, Hugo C, Linkermann A.

Cell Death Dis. 2018 Mar 2;9(3):359. doi: 10.1038/s41419-018-0394-3. Erratum in: Cell Death Dis. 2018 May 24;9(6):622.

7.

The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials.

Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, Nankivell BJ, Halloran PF, Colvin RB, Akalin E, Alachkar N, Bagnasco S, Bouatou Y, Becker JU, Cornell LD, van Huyen JPD, Gibson IW, Kraus ES, Mannon RB, Naesens M, Nickeleit V, Nickerson P, Segev DL, Singh HK, Stegall M, Randhawa P, Racusen L, Solez K, Mengel M.

Am J Transplant. 2018 Feb;18(2):293-307. doi: 10.1111/ajt.14625. Epub 2018 Jan 21.

8.

Mycophenolate mofetil following glucocorticoid treatment in Henoch-Schönlein purpura nephritis: the role of early initiation and therapeutic drug monitoring.

Hackl A, Becker JU, Körner LM, Ehren R, Habbig S, Nüsken E, Nüsken KD, Ebner K, Liebau MC, Müller C, Pohl M, Weber LT.

Pediatr Nephrol. 2018 Apr;33(4):619-629. doi: 10.1007/s00467-017-3846-6. Epub 2017 Nov 25.

PMID:
29177628
9.

Glomerulocapillary miRNA response to HLA-class I antibody in vitro and in vivo.

Heinemann FM, Jindra PT, Bockmeyer CL, Zeuschner P, Wittig J, Höflich H, Eßer M, Abbas M, Dieplinger G, Stolle K, Vester U, Hoyer PF, Immenschuh S, Heinold A, Horn PA, Li W, Eisenberger U, Becker JU.

Sci Rep. 2017 Nov 6;7(1):14554. doi: 10.1038/s41598-017-14674-5. Erratum in: Sci Rep. 2018 Apr 12;8(1):6003.

10.

[Report from the Heart, Vascular, Renal, and Transplantation Pathology Working Group].

Becker JU.

Pathologe. 2017 Nov;38(Suppl 2):228. doi: 10.1007/s00292-017-0376-8. German. No abstract available.

PMID:
29098366
11.

Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis.

Schreiber A, Rousselle A, Becker JU, von Mässenhausen A, Linkermann A, Kettritz R.

Proc Natl Acad Sci U S A. 2017 Nov 7;114(45):E9618-E9625. doi: 10.1073/pnas.1708247114. Epub 2017 Oct 24.

12.

Regulation of Arthritis Severity by the Acid Sphingomyelinase.

Beckmann N, Becker KA, Walter S, Becker JU, Kramer M, Hessler G, Weber S, Göthert JR, Fassbender K, Gulbins E, Carpinteiro A.

Cell Physiol Biochem. 2017;43(4):1460-1471. doi: 10.1159/000481968. Epub 2017 Oct 16.

13.

ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences.

Gong YN, Guy C, Olauson H, Becker JU, Yang M, Fitzgerald P, Linkermann A, Green DR.

Cell. 2017 Apr 6;169(2):286-300.e16. doi: 10.1016/j.cell.2017.03.020.

14.

Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group.

Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J; IgAN Classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society; Conference Participants.

Kidney Int. 2017 May;91(5):1014-1021. doi: 10.1016/j.kint.2017.02.003. Epub 2017 Mar 22. Review.

15.

The Banff 2015 Kidney Meeting Report: Current Challenges in Rejection Classification and Prospects for Adopting Molecular Pathology.

Loupy A, Haas M, Solez K, Racusen L, Glotz D, Seron D, Nankivell BJ, Colvin RB, Afrouzian M, Akalin E, Alachkar N, Bagnasco S, Becker JU, Cornell L, Drachenberg C, Dragun D, de Kort H, Gibson IW, Kraus ES, Lefaucheur C, Legendre C, Liapis H, Muthukumar T, Nickeleit V, Orandi B, Park W, Rabant M, Randhawa P, Reed EF, Roufosse C, Seshan SV, Sis B, Singh HK, Schinstock C, Tambur A, Zeevi A, Mengel M.

Am J Transplant. 2017 Jan;17(1):28-41. doi: 10.1111/ajt.14107.

16.

Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries.

Bábíčková J, Klinkhammer BM, Buhl EM, Djudjaj S, Hoss M, Heymann F, Tacke F, Floege J, Becker JU, Boor P.

Kidney Int. 2017 Jan;91(1):70-85. doi: 10.1016/j.kint.2016.07.038. Epub 2016 Sep 24.

PMID:
27678159
17.

A Multicenter Study of the Predictive Value of Crescents in IgA Nephropathy.

Haas M, Verhave JC, Liu ZH, Alpers CE, Barratt J, Becker JU, Cattran D, Cook HT, Coppo R, Feehally J, Pani A, Perkowska-Ptasinska A, Roberts IS, Soares MF, Trimarchi H, Wang S, Yuzawa Y, Zhang H, Troyanov S, Katafuchi R.

J Am Soc Nephrol. 2017 Feb;28(2):691-701. doi: 10.1681/ASN.2016040433. Epub 2016 Sep 9. Erratum in: J Am Soc Nephrol. 2017 May;28(5):1665.

18.

Comparison of different normalization strategies for the analysis of glomerular microRNAs in IgA nephropathy.

Bockmeyer CL, Säuberlich K, Wittig J, Eßer M, Roeder SS, Vester U, Hoyer PF, Agustian PA, Zeuschner P, Amann K, Daniel C, Becker JU.

Sci Rep. 2016 Aug 24;6:31992. doi: 10.1038/srep31992.

19.

Live or Let Die: Is There any Cell Death in Podocytes?

Braun F, Becker JU, Brinkkoetter PT.

Semin Nephrol. 2016 May;36(3):208-19. doi: 10.1016/j.semnephrol.2016.03.008. Review.

PMID:
27339386
20.

Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC).

Abbas M, Steffens S, Bellut M, Eggers H, Großhennig A, Becker JU, Wegener G, Schrader AJ, Grünwald V, Ivanyi P.

Med Oncol. 2016 Jul;33(7):80. doi: 10.1007/s12032-016-0794-0. Epub 2016 Jun 17.

PMID:
27317388

Supplemental Content

Loading ...
Support Center